The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sadretdinova L.D.

Bashkir State Medical University

Gantseva Kh.Kh.

Bashkir State Medical University

Vishnyakov D.S.

Bashkir State Medical University

Golubyatnikov V.B.

Bashkir State Medical University

Kalimullina D.Kh.

Bashkir State Medical University

Pavlov V.N.

Bashkir State Medical University

Tyurin A.V.

Bashkir State Medical University

Gastrointestinal injury in COVID-19

Authors:

Sadretdinova L.D., Gantseva Kh.Kh., Vishnyakov D.S., Golubyatnikov V.B., Kalimullina D.Kh., Pavlov V.N., Tyurin A.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(7): 106‑115

Read: 5633 times


To cite this article:

Sadretdinova LD, Gantseva KhKh, Vishnyakov DS, Golubyatnikov VB, Kalimullina DKh, Pavlov VN, Tyurin AV. Gastrointestinal injury in COVID-19. Russian Journal of Preventive Medicine. 2022;25(7):106‑115. (In Russ.)
https://doi.org/10.17116/profmed202225071106

Recommended articles:
Gut microbiota: role in human health and pote­ntial for personalized medi­cine. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):81-88
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146

References:

  1. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio-Medica: Atenei Parmensis. 2020;91(1):157-160.  https://doi.org/10.23750/abm.v91i1.9397
  2. Chislo inficirovannyh COVID-19 v mire prevysilo 194 mln chelovek. Accessed June 01, 2022. https://www.interfax.ru/world/780729
  3. World Health Organization. COVID-19. Weekly Epidemiological Update on COVID-19. 2021. Accessed June 01, 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-20-april-2021
  4. China CDC Shares Latest COVID-19 Data. Accessed June 01, 2022. https://www.gisaid.org
  5. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK; Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. 2020;382(10):929-936.  https://doi.org/10.1056/NEJMoa2001191
  6. Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, Yip CCY, Leung KH, Fung AY, Zhang RR, Lin Y, Cheng HM, Zhang AJX, To KKW, Chan KH, Yuen KY, Leung WK. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020;159(1):81-95.  https://doi.org/10.1053/j.gastro.2020.03.065
  7. Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, Li XL, Chen CX, Lu XX, Liu ZS, Lu W, Chen CB, Jiao R, Zhang AM, Wang JT, Ding XW, Zeng YG, Cheng LP, Huang QF, Wu J, Luo XC, Wang ZJ, Zhong YY, Bai Y, Wu XY, Jin RM. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Current Medical Science. 2020;40(2):275-280.  https://doi.org/10.1007/s11596-020-2172-6
  8. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nature Medicine. 2020;26(7):1017-1032. https://doi.org/10.1038/s41591-020-0968-3
  9. Sierpiński R, Pinkas J, Jankowski M, Zgliczyński WS, Wierzba W, Gujski M, Szumowski Ł. Sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders in 1942 nonhospitalized patients with coronavirus disease 2019 (COVID-19). Polish Archives of Internal Medicine. 2020;130(6):501-505.  https://doi.org/10.20452/pamw.15414
  10. Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, Xu W, Zhang C, Yu J, Jiang B, Cao H, Li L. Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study. Clinical Infectious Diseases. 2020;71(15):706-712.  https://doi.org/10.1093/cid/ciaa199
  11. CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12 — March 28, 2020. MMWR. Morbidity and Mortality Weekly Report. 2020;69(13):382-386.  https://doi.org/10.15585/mmwr.mm6913e2
  12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.  https://doi.org/10.1016/S0140-6736(20)30211-7
  13. Papa A, Covino M, Pizzolante F, Miele L, Lopetuso LR, Bove V, Iorio R, Simeoni B, Vetrone LM, Tricoli L, Mignini I, Schepis T, D’Alessandro A, Coppola G, Nicoletti T, Visconti E, Rapaccini G. Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19. European Review for Medical and Pharmacological Sciences. 2020; 24(13):7506-7511. https://doi.org/10.26355/eurrev_202007_21923
  14. Yang TY, Li YC, Wang SC, Dai QQ, Jiang XS, Zuo S, Jia L, Zheng JB, Wang HL. Clinical characteristics of patients with COVID-19 presenting with gastrointestinal symptoms as initial symptoms: Retrospective case series. World Journal of Clinical Cases. 2020;8(14):2950-2958. https://doi.org/10.12998/wjcc.v8.i14.2950
  15. Pizuorno A, Fierro NA, Copado-Villagrana ED, Herrera-Solís ME, Oskrochi G, Brim H, Ashktorab H. COVID-19 and gastrointestinal symptoms in Mexico, a systematic review: does location matter? BMC Infectious Diseases. 2021;21(1):555.  https://doi.org/10.1186/s12879-021-06252-y
  16. Chung H, Seo H, Park S, Kim H, Jung J, Chong YP, Kim SH, Lee SO, Choi SH, Kim YS, Kim MJ. The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea. Journal of Korean Medical Science. 2021;36(25):e181. https://doi.org/10.3346/jkms.2021.36.e181
  17. Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, Lee EH, Paneth-Pollak R, Geevarughese A, Lash MK, Dorsinville MS, Ballen V, Eiras DP, Newton-Cheh C, Smith E, Robinson S, Stogsdill P, Lim S, Fox SE, Richardson G, Hand J, Oliver NT, Kofman A, Bryant B, Ende Z, Datta D, Belay E, Godfred-Cato S. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March-August 2020. MMWR. Morbidity and Mortality Weekly Report. 2020;69(40):1450-1456. https://doi.org/10.15585/mmwr.mm6940e1
  18. Maghool F, Valiani A, Safari T, Emami MH, Mohammadzadeh S. Gastrointestinal and renal complications in sars-cov-2-infected patients: Role of immune system. Scandinavian Journal of Immunology. 2021;93(4):e12999. https://doi.org/10.1111/sji.12999
  19. Delgado-Gonzalez P, Gonzalez-Villarreal CA, Roacho-Perez JA, Quiroz-Reyes AG, Islas JF, Delgado-Gallegos JL, Arellanos-Soto D, Galan-Huerta KA, Garza-Treviño EN. Inflammatory effect on the gastrointestinal system associated with COVID-19. World Journal of Gastroenterology. 2021; 27(26):4160-4171. https://doi.org/10.3748/wjg.v27.i26.4160
  20. Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020; 369(6499):50-54.  https://doi.org/10.1126/science.abc1669
  21. Medema G, Heijnen L, Elsinga G, Italiaander R, Brouwer AJ. Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in the Netherlands. Environmental Science and Technology Letters. medRxiv: The Preprint Server for Health Sciences. 2020. https://doi.org/10.1101/2020.03.29.20045880
  22. Zhou J, Li C, Liu X, Chiu MC, Zhao X, Wang D, Wei Y, Lee A, Zhang AJ, Chu H, Cai JP, Yip CC, Chan IH, Wong KK, Tsang OT, Chan KH, Chan JF, To KK, Chen H, Yuen KY. Infection of bat and human intestinal organoids by SARS-CoV-2. Nature Medicine. 2020;26(7):1077-1083. https://doi.org/10.1038/s41591-020-0912-6
  23. Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterology and Motility. 2021;33(3):e14104. https://doi.org/10.1111/nmo.14104
  24. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology. 2020;94(7): e00127-20.  https://doi.org/10.1128/JVI.00127-20
  25. Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nature Reviews. Gastroenterology and Hepatology. 2021;18(4):269-283.  https://doi.org/10.1038/s41575-021-00416-6
  26. Feng Y, Zeng D, Hu, L, Yang Y, Song S, Shi Y, Xu J, Guo W, Ling Y, Qi T, Wu Q, Li F, Cheng J, Lu H. Case report: histopathology and molecular pathology analysis on enteric tissue of a COVID-19 patient. Diagnostic Pathology. 2021;16(1):40.  https://doi.org/10.1186/s13000-021-01082-7
  27. Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomedicine and Pharmacotherapy. 2021; 133:111064. https://doi.org/10.1016/j.biopha.2020.111064
  28. Horvat N, Pinto PVA, Araujo-Filho JAB, Santos JMMM, Dias AB, Miranda JA, de Oliveira CV, Barbosa CS, Morais TC, N Assuncao-Jr A, Nomura CH, Viana PCC. Abdominal gastrointestinal imaging findings on computed tomography in patients with COVID-19 and correlation with clinical outcomes. European Journal of Radiology Open. 2021;8:100326. https://doi.org/10.1016/j.ejro.2021.100326
  29. Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, Ellingson MK, Mao T, Oh JE, Israelow B, Takahashi T, Tokuyama M, Lu P, Venkataraman A, Park A, Mohanty S, Wang H, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ, Muenker MC, Fournier JB, Campbell M, Odio CD, Casanovas-Massana A; Yale IMPACT Team, Herbst R, Shaw AC, Medzhitov R, Schulz WL, Grubaugh ND, Dela Cruz C, Farhadian S, Ko AI, Omer SB, Iwasaki A. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463-469.  https://doi.org/10.1038/s41586-020-2588-y
  30. Azramezani Kopi T, Shahrokh S, Mirzaei S, Asadzadeh Aghdaei H, Amini Kadijani A. The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study. Gastroenterology and Hepatology from Bed to Bench. 2019;12(3):183-189. 
  31. Giuffrè M, Vetrugno L, Di Bella S, Moretti R, Berretti D, Crocè LS. Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature. Healthcare. 2021;9(8):956.  https://doi.org/10.3390/healthcare9080956
  32. Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, Müller T, Adolph TE, Tilg H. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69(8):1543-1544. https://doi.org/10.1136/gutjnl-2020-321388
  33. Zerbato V, Di Bella S, Giuffrè M, Jaracz AW, Gobbo Y, Luppino D, Macor P, Segat L, Koncan R, D’Agaro P, Valentini M, Crocé LS, Ruscio M, Luzzati R. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study. World Journal of Gastroenterology. 2021;27(22):3130-3137. https://doi.org/10.3748/wjg.v27.i22.3130
  34. Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, Eggers J, Mogno I, Gonzalez-Reiche AS, Siu S, Tankelevich M, Grinspan LT, Dixon RE, Jha D, Martínez-Delgado G, Amanat F, Hoagland DA, tenOever BR, Dubinsky MC, Merad M, van Bakel H, Krammer F, Bongers G, Mehandru S, Faith JJ. SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19. medRxiv: The Preprint Server for Health Sciences. 2020. https://doi.org/10.1101/2020.09.03.20183947
  35. Grabherr F, Effenberger M, Pedrini A, Mayr L, Schwärzler J, Reider S, Enrich B, Fritsche G, Wildner S, Bellmann-Weiler R, Weiss G, Scholl-Bürgi S, Müller T, Moschen A, Adolph TE, Tilg H. Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19. Clinical and Translational Gastroenterology. 2021;12(1):e00293. https://doi.org/10.14309/ctg.0000000000000293
  36. Zhu S, Ding S, Wang P, Wei Z, Pan W, Palm NW, Yang Y, Yu H, Li HB, Wang G, Lei X, de Zoete MR, Zhao J, Zheng Y, Chen H, Zhao Y, Jurado KA, Feng N, Shan L, Kluger Y, Lu J, Abraham C, Fikrig E, Greenberg HB, Flavell RA. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells. Nature. 2017;546(7660):667-670.  https://doi.org/10.1038/nature22967
  37. Chen J, Hall S, Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Reviews in Medical Virology. 2021; 31(5):1-13.  https://doi.org/10.1002/rmv.2211
  38. Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications. 2020;526(1):135-140.  https://doi.org/10.1016/j.bbrc.2020.03.044
  39. Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S. Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection. Infection and Drug Resistance. 2021;14:1645-1648. https://doi.org/10.2147/IDR.S305349
  40. Hawes AM, Desai A, Patel PK. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Anaerobe. 2021;70: 102384. https://doi.org/10.1016/j.anaerobe.2021.102384
  41. Voona S, Abdic H, Montgomery R, Clarkson A, Twitchell H, Hills T, Briggs S, Crooks C, Monaghan TM. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre. Anaerobe. 2022; 73:102479. https://doi.org/10.1016/j.anaerobe.2021.102479
  42. Granata G, Bartoloni A, Codeluppi M, Contadini I, Cristini F, Fantoni M, Ferraresi A, Fornabaio C, Grasselli S, Lagi F, Masucci L, Puoti M, Raimondi A, Taddei E, Trapani FF, Viale P, Johnson S, Petrosillo N, On Behalf Of The CloVid Study Group. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid). Journal of Clinical Medicine. 2020;9(12):3855. https://doi.org/10.3390/jcm9123855
  43. Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World Journal of Clinical Cases. 2021;9(33):10180-10188. https://doi.org/10.12998/wjcc.v9.i33.10180
  44. Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, Li Z, Cui X, Xiao J, Zhan J, Meng T, Zhou W, Liu J, Xu H. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69(6):1010-1018. https://doi.org/10.1136/gutjnl-2020-320953
  45. Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L, Kobayashi LY, Vaishnav ED, Subramanian A, Smilie C, Jagadeesh K, Duong ET, Fiskin E, Triglia ET, Ansari M, CaiP, Lin B, Buchanan J, Chen S, Shu J, Haber AL, Chung H, Montoro DT, Adams T, Aliee H, Samuel J, Andrusivova AZ, Angelidis I, Ashenberg O, Bassler K, Bécavin C, Benhar I, Bergenstråhle J, Bergenstråhle L, Bolt L, Braun E, Bui LT, Chaffin M, Chichelnitskiy E, Chiou J, Conlon TM, Cuoco MS, Deprez M, Fischer DS, Gillich A, Gould J, Guo M, Gutierrez AJ, Habermann AC, Harvey T, He P, Hou X, Hu L, Jaiswal A, Jiang P, Kapellos T, Kuo CS, Larsson L, Leney-Greene MA, Lim K, Litviňuková M, Lu J, Maatz H, Madissoon E, Mamanova L, Manakongtreecheep K, Marquette CH, Mbano I, McAdams AM, Metzger RJ, Nabhan AN, Nyquist SK, Ordovas-Montanes J, Penland L, Poirion OB, Poli S, Qi CC, Reichart D, Rosas I, Schupp J, SinhaR, Sit RV, Slowikowski K, Slyper M, Smith N, Sountoulidis A, Strunz M, Sun D, Talavera-López C, Tan P, Tantivit J, Travaglini KJ, Tucker NR, Vernon K, Wadsworth MH, Waldmann J, Wang X, Yan W, Zhao W, Ziegler CGK, The NHLBI LungMAP Consortium, and The Human Cell Atlas Lung Biological Network. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiv. 2020;2020.04.19.049254. https://doi.org/10.1101/2020.04.19.049254
  46. Zellmer S, Hanses F, Muzalyova A, Classen J, Braun G, Piepel C, Erber J, Pilgram L, Walter L, Göpel S, Wille K, Hower M, Rüthrich MM, Rupp J, Degenhardt C, Voigt I, Borgmann S, Stecher M, Jakob C, Dhillon C, Messmann H, Ebigbo A, Römmele C; LEOSS study group. Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries. United European Gastroenterology Journal. 2021;9(9):1081-1090. https://doi.org/10.1002/ueg2.12165
  47. Chen J, Hang Y. Characteristics, risk factors and outcomes of gastrointestinal hemorrhage in COVID-19 patients: A meta-analysis. Pakistan Journal of Medical Sciences. 2021;37(5):1524-1531. https://doi.org/10.12669/pjms.37.5.4351
  48. Ding P, Song B, Liu X, Fang X, Cai H, Zhang D, Zheng X. Elevated Pancreatic Enzymes in ICU Patients with COVID-19 in Wuhan, China: A Retrospective Study. Frontiers in Medicine. 2021;8:663646. https://doi.org/10.3389/fmed.2021.663646
  49. Inamdar S, Benias PC, Liu Y, Sejpal DV, Satapathy SK, Trindade AJ; Northwell COVID-19 Research Consortium. Prevalence, Risk Factors, and Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Presenting as Acute Pancreatitis. Gastroenterology. 2020;159(6):2226-2228.e2.  https://doi.org/10.1053/j.gastro.2020.08.044
  50. Dirweesh A, Li Y, Trikudanathan G, Mallery JS, Freeman ML, Amateau SK. Clinical Outcomes of Acute Pancreatitis in Patients with Coronavirus Disease 2019. Gastroenterology. 2020;159(5):1972-1974. https://doi.org/10.1053/j.gastro.2020.07.038
  51. Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterology Journal. 2021;9(7):750-765.  https://doi.org/10.1002/ueg2.12115
  52. Shaharuddin SH, Wang V, Santos RS, Gross A, Wang Y, Jawanda H, Zhang Y, Hasan W, Garcia G Jr, Arumugaswami V, Sareen D. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells. Frontiers in Cellular and Infection Microbiology. 2021;11:678482. https://doi.org/10.3389/fcimb.2021.678482
  53. Parasar K, Mohan S, John AG, Anand U. Pain in Chronic Pancreatitis During the COVID-19 Lockdown: Has It Given Us a New Dimension for Treatment? Cureus. 2021;13(2):e13423. https://doi.org/10.7759/cureus.13423
  54. Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. Journal of Clinical Gastroenterology. 2021;55(1):1-11.  https://doi.org/10.1097/MCG.0000000000001459
  55. Łykowska-Szuber L, Wołodźko K, Rychter AM, Szymczak-Tomczak A, Krela-Kaźmierczak I, Dobrowolska A. Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review. Journal of Clinical Medicine. 2021;10(21):5048. https://doi.org/10.3390/jcm10215048
  56. Gao F, Zheng KI, Fan YC, Targher G, Byrne CD, Zheng MH. ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis. The American Journal of Gastroenterology. 2020;115(9):1544. https://doi.org/10.14309/ajg.0000000000000780
  57. Sharma P, Kumar A, Anikhindi S, Bansal N, Singla V, Shivam K, Arora A. Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? Journal of Clinical and Experimental Hepatology. 2021;11(4):484-493.  https://doi.org/10.1016/j.jceh.2020.12.006
  58. Dongiovanni P, Meroni M, Longo M, Fracanzani AL. MAFLD in COVID-19 patients: an insidious enemy. Expert Review of Gastroenterology and Hepatology. 2020;14(10):867-872.  https://doi.org/10.1080/17474124.2020.1801417
  59. Zhang B, Huang W, Zhang S. Clinical Features and Outcomes of Coronavirus Disease 2019 (COVID-19) Patients With Chronic Hepatitis B Virus Infection. Clinical Gastroenterology and Hepatology. 2020;18(11):2633-2637. https://doi.org/10.1016/j.cgh.2020.06.011
  60. Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World Journal of Gastroenterology. 2021;27(5):377-390.  https://doi.org/10.3748/wjg.v27.i5.377
  61. Kumric M, Ticinovic Kurir T, Martinovic D, Zivkovic PM, Bozic J. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence. World Journal of Gastroenterology. 2021;27(25): 3748-3761. https://doi.org/10.3748/wjg.v27.i25.3748
  62. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020;159(2):481-491.  https://doi.org/10.1053/j.gastro.2020.05.032
  63. Alzahrani MA, Alshamrani AS, Ahmasani IM, Alahmari FS, Asiri AH, Alshehri AM, Alsamghan AS, Awadalla NJ. Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia. Medicine. 2020;99(51):e23711. https://doi.org/10.1097/MD.0000000000023711
  64. Nass BYS, Dibbets P, Markus CR. Impact of the COVID-19 pandemic on inflammatory bowel disease: The role of emotional stress and social isolation. Stress and Health. 2022;38(2):222-233.  https://doi.org/10.1002/smi.3080

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.